- Home
- GILD vs FI Comparison
GILD vs FI Comparison
Compare GILD & FI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- FI
- Stock Information
- Founded
- GILD 1987
- FI 1984
- Country
- GILD United States
- FI United States
- Employees
- GILD N/A
- FI N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- FI Business Services
- Sector
- GILD Health Care
- FI Consumer Discretionary
- Exchange
- GILD Nasdaq
- FI Nasdaq
- Market Cap
- GILD 129.9B
- FI 88.3B
- IPO Year
- GILD 1992
- FI 1986
- Fundamental
- Price
- GILD $110.08
- FI $162.76
- Analyst Decision
- GILD Buy
- FI Strong Buy
- Analyst Count
- GILD 25
- FI 24
- Target Price
- GILD $109.00
- FI $229.70
- AVG Volume (30 Days)
- GILD 8.8M
- FI 6.7M
- Earning Date
- GILD 04-24-2025
- FI 07-23-2025
- Dividend Yield
- GILD 2.87%
- FI N/A
- EPS Growth
- GILD 1118.07
- FI 5.73
- EPS
- GILD 4.73
- FI 5.65
- Revenue
- GILD $28,735,000,000.00
- FI $20,703,000,000.00
- Revenue This Year
- GILD $1.54
- FI $5.10
- Revenue Next Year
- GILD $3.70
- FI $8.53
- P/E Ratio
- GILD $23.27
- FI $28.81
- Revenue Growth
- GILD 4.68
- FI 6.56
- 52 Week Low
- GILD $62.07
- FI $146.25
- 52 Week High
- GILD $119.96
- FI $238.59
- Technical
- Relative Strength Index (RSI)
- GILD 58.78
- FI 36.58
- Support Level
- GILD $107.23
- FI $156.30
- Resistance Level
- GILD $109.55
- FI $161.75
- Average True Range (ATR)
- GILD 2.90
- FI 6.01
- MACD
- GILD 1.01
- FI -0.07
- Stochastic Oscillator
- GILD 90.02
- FI 18.14
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About FI Fiserv Inc.
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Through the merger with First Data in 2019, Fiserv also provides payment processing services for merchants. About 10% of the company's revenue is generated internationally.